Artelo Biosciences, Inc.
ARTL
$9.35
-$0.18-1.89%
NASDAQ
| 06/30/2025 | 03/31/2025 | 12/31/2024 | 09/30/2024 | 06/30/2024 | |
|---|---|---|---|---|---|
| Net Income | -10.50M | -9.72M | -9.83M | -9.12M | -10.44M |
| Total Depreciation and Amortization | -- | -- | -- | -- | -- |
| Total Amortization of Deferred Charges | 54.00K | -- | -- | -- | -- |
| Total Other Non-Cash Items | 689.00K | 654.00K | 569.00K | 455.00K | 367.00K |
| Change in Net Operating Assets | 4.30M | 2.06M | 907.00K | 287.00K | 668.00K |
| Cash from Operations | -5.46M | -7.01M | -8.35M | -8.38M | -9.40M |
| Capital Expenditure | -- | -- | -- | -- | -- |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | 4.75M | 6.50M | 7.77M | 10.01M | 3.93M |
| Cash from Investing | 4.75M | 6.50M | 7.77M | 10.01M | 3.93M |
| Total Debt Issued | 737.00K | -- | -- | -- | -- |
| Total Debt Repaid | -- | -- | -- | -- | -- |
| Issuance of Common Stock | 1.14M | 57.00K | 112.00K | 87.00K | 622.00K |
| Repurchase of Common Stock | -- | -- | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -- | -- | -- | -- | -- |
| Cash from Financing | 1.87M | 57.00K | 112.00K | 87.00K | 622.00K |
| Foreign Exchange rate Adjustments | 18.00K | -1.00K | -8.00K | 0.00 | 15.00K |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | 1.19M | -449.00K | -477.00K | 1.72M | -4.84M |